493 related articles for article (PubMed ID: 31551757)
1. Accelerated Ovarian Failure as a Unique Model to Study Peri-Menopause Influence on Alzheimer's Disease.
Marongiu R
Front Aging Neurosci; 2019; 11():242. PubMed ID: 31551757
[TBL] [Abstract][Full Text] [Related]
2. Increased Alzheimer's risk during the menopause transition: A 3-year longitudinal brain imaging study.
Mosconi L; Rahman A; Diaz I; Wu X; Scheyer O; Hristov HW; Vallabhajosula S; Isaacson RS; de Leon MJ; Brinton RD
PLoS One; 2018; 13(12):e0207885. PubMed ID: 30540774
[TBL] [Abstract][Full Text] [Related]
3. Development of a Chemical Reproductive Aging Model in Female Rats.
Pestana-Oliveira N; Carolino ROG; Kalil-Cutti B; Leite CM; Dalpogeto LC; De Paula BB; Collister JP; Anselmo-Franci J
Bio Protoc; 2021 Apr; 11(8):e3994. PubMed ID: 34124295
[TBL] [Abstract][Full Text] [Related]
4. Endogenous and Exogenous Estrogen Exposures: How Women's Reproductive Health Can Drive Brain Aging and Inform Alzheimer's Prevention.
Jett S; Malviya N; Schelbaum E; Jang G; Jahan E; Clancy K; Hristov H; Pahlajani S; Niotis K; Loeb-Zeitlin S; Havryliuk Y; Isaacson R; Brinton RD; Mosconi L
Front Aging Neurosci; 2022; 14():831807. PubMed ID: 35356299
[TBL] [Abstract][Full Text] [Related]
5. Female Sex and Alzheimer's Risk: The Menopause Connection.
Scheyer O; Rahman A; Hristov H; Berkowitz C; Isaacson RS; Diaz Brinton R; Mosconi L
J Prev Alzheimers Dis; 2018; 5(4):225-230. PubMed ID: 30298180
[TBL] [Abstract][Full Text] [Related]
6. Redistribution of NMDA Receptors in Estrogen-Receptor-β-Containing Paraventricular Hypothalamic Neurons following Slow-Pressor Angiotensin II Hypertension in Female Mice with Accelerated Ovarian Failure.
Marques-Lopes J; Tesfaye E; Israilov S; Van Kempen TA; Wang G; Glass MJ; Pickel VM; Iadecola C; Waters EM; Milner TA
Neuroendocrinology; 2017; 104(3):239-256. PubMed ID: 27078860
[TBL] [Abstract][Full Text] [Related]
7. Estrogen Receptor β Contributes to Both Hypertension and Hypothalamic Plasticity in a Mouse Model of Peri-Menopause.
Milner TA; Contoreggi NH; Yu F; Johnson MA; Wang G; Woods C; Mazid S; Van Kempen TA; Waters EM; McEwen BS; Korach KS; Glass MJ
J Neurosci; 2021 Jun; 41(24):5190-5205. PubMed ID: 33941651
[TBL] [Abstract][Full Text] [Related]
8. Accelerated ovarian failure: a novel, chemically induced animal model of menopause.
Van Kempen TA; Milner TA; Waters EM
Brain Res; 2011 Mar; 1379():176-87. PubMed ID: 21211517
[TBL] [Abstract][Full Text] [Related]
9. Hippocampal glial inflammatory markers are differentially altered in a novel mouse model of perimenopausal cerebral amyloid angiopathy.
Platholi J; Marongiu R; Park L; Yu F; Sommer G; Weinberger R; Tower W; Milner TA; Glass MJ
Front Aging Neurosci; 2023; 15():1280218. PubMed ID: 38035277
[TBL] [Abstract][Full Text] [Related]
10. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
11. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis.
Hogervorst E; Williams J; Budge M; Riedel W; Jolles J
Neuroscience; 2000; 101(3):485-512. PubMed ID: 11113299
[TBL] [Abstract][Full Text] [Related]
12. Brain insulin signalling, glucose metabolism and females' reproductive aging: A dangerous triad in Alzheimer's disease.
Duarte AI; Santos MS; Oliveira CR; Moreira PI
Neuropharmacology; 2018 Jul; 136(Pt B):223-242. PubMed ID: 29471055
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
14. Organ of hearing and balance in peri- and postmenopausal women. Effects of hormone replacement therapy on hearing and balance in peri- and post-menopausal women: The current state of knowledge.
Orendorz-Frączkowska K; Temporale H
Adv Clin Exp Med; 2020 Jun; 29(6):751-755. PubMed ID: 32589823
[TBL] [Abstract][Full Text] [Related]
15. Ovarian steroid hormones: A long overlooked but critical contributor to brain aging and Alzheimer's disease.
Jett S; Schelbaum E; Jang G; Boneu Yepez C; Dyke JP; Pahlajani S; Diaz Brinton R; Mosconi L
Front Aging Neurosci; 2022; 14():948219. PubMed ID: 35928995
[TBL] [Abstract][Full Text] [Related]
16. Climacteric: concept, consequence and care.
Taechakraichana N; Jaisamrarn U; Panyakhamlerd K; Chaikittisilpa S; Limpaphayom KK
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S1-15. PubMed ID: 12188398
[TBL] [Abstract][Full Text] [Related]
17. Age, APOE and sex: Triad of risk of Alzheimer's disease.
Riedel BC; Thompson PM; Brinton RD
J Steroid Biochem Mol Biol; 2016 Jun; 160():134-47. PubMed ID: 26969397
[TBL] [Abstract][Full Text] [Related]
18. Body composition and muscle performance during menopause and hormone replacement therapy.
Sipilä S
J Endocrinol Invest; 2003 Sep; 26(9):893-901. PubMed ID: 14964443
[TBL] [Abstract][Full Text] [Related]
19. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
[TBL] [Abstract][Full Text] [Related]
20. The endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive disease.
Atwood CS; Bowen RL
Horm Behav; 2015 Nov; 76():63-80. PubMed ID: 26188949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
